Abstract: The present invention relates to novel type of monoterpene synthase, a key enzyme in the production of the monoterpene aroma compound geraniol. More specifically, the present invention relates to nucleic acid sequences coding for CUES from flowers and herbs species, in particular sweet basil, as well as to vectors containing the sequences, to host cells containing the sequences and to methods of producing recombinant GES, its products, and uses thereof.
Type:
Grant
Filed:
December 2, 2004
Date of Patent:
April 27, 2010
Assignees:
The Regents of The University of Michigan, Arizona Board of Regents on Behalf of The University of Arizona, Agricultural Research Organization Ministry of Agriculture and Rural Development
Inventors:
Eran Pichersky, Yoko Iijima, Efraim Lewinsohn, David R. Gang, James Simon
Abstract: The invention provides a composition for attenuating neovascularization crising administering a pharmaceutically effective amount of a compound of formula I: ##STR1## wherein: n=1 or 2; R.sub.1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy;R.sub.2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, andR.sub.3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;as an active ingredient therein, in combination with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
May 26, 1998
Date of Patent:
July 18, 2000
Assignees:
Agricultural Research Organization Ministry of Agriculture, Hadasit Medical Research Services & Development Company, Ltd.
Inventors:
Arnon Nagler, Shimon Slavin, Israel Vlodavsky, Mark Pines
Abstract: The invention provides a composition for attenuating mesangial cell proliation, comprising an amount of a compound of formula 1: ##STR1## wherein: "n=1 or 2"R.sup.1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower, alkyl, phenyl and lower alkoxy;R.sub.2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, andR.sub.3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;effective to attenuate mesangial cell proliferation and the physiologically acceptable salts thereof.
Type:
Grant
Filed:
June 23, 1997
Date of Patent:
December 7, 1999
Assignees:
Agricultural Research Organization, Ministry of Agriculture, Hadasit Medical Research Services & Development Company Ltd.
Inventors:
Arnon Nagler, Shimon Slavin, Israel Vlodavsky, Mark Pines
Abstract: The invention provides an anti-fibrotic composition, comprising an amount a compound of formula I: ##STR1## wherein: n=1 or 2R.sub.1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy;R.sub.2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, andR.sub.3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl;effective to inhibit collagen type I synthesis as active ingredient therein.
Type:
Grant
Filed:
January 14, 1994
Date of Patent:
September 12, 1995
Assignees:
Agricultural Research Organization, Ministry of Agriculture, Hadasit Medical Research Services & Development Company Ltd.
Inventors:
Mark Pines, Arnon Nagler, Shimon Slavin
Abstract: An inhibitor of adhesion formation which can be used to prevent adhesions within the abdominal cavity, particularly following surgical intervention, trauma or inflammation in the area is disclosed. Specifically, the most preferred compound of the present invention. Halofuginone, can be used to prevent collagen deposition from occurring within the peritoneum after surgical intervention, thereby inhibiting adhesion formation. Halofuginone, and related compounds, are useful in the prevention and treatment of both inflammatory and surgically induced adhesions, and in the treatment of congenital adhesions.
Type:
Grant
Filed:
December 8, 2000
Date of Patent:
September 3, 2002
Assignees:
Hadasit Medical Research Services & Development Co.,
Ltd., Agricultural Research Organization-Ministry of
Agriculture
Abstract: The invention provides a composition for attenuating neovascularization and treating malignancies, including a pharmaceutically effective amount of a compound having a formula: wherein: R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy; R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, and R3 is a member of the group consisting of hydrogen and lower alkenoxy carbonyl; as active ingredient therein, in combination with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
December 20, 2000
Date of Patent:
April 17, 2007
Assignees:
Hadasit Medical Research Services and Development Company Ltd., Agricultural Research Organization Ministry of Agriculture
Inventors:
Mark Pines, Israel Vlodavsky, Arnon Nagler, Hua-Quan Mian